RSV infections are a major burden in infants less than 3 months of age. Newborns and infants express a distinct immune system that is largely dependent on innate immunity and passive immunity from maternal antibodies. Antibodies can regulate immune responses against viruses through interaction with Fc gamma receptors leading to enhancement or neutralization of viral infections. The mechanisms underlying the immunomodulatory effect of Fc gamma receptors on viral infections have yet to be elucidated in infants. Herein, we will discuss current knowledge of the effects of antibodies and Fc gamma receptors on infant innate immunity to RSV. A better understanding of the pathogenesis of RSV infections in young infants may provide insight into nove...
The exact cause of severe disease in children during primary RSV infections is not completely clear....
The exact cause of severe disease in children during primary RSV infections is not completely clear....
Respiratory syncytial virus (RSV) represents an important target for vaccine development. The design...
Item does not contain fulltextRSV infections are a major burden in infants less than 3 months of age...
Respiratory syncytial virus (RSV) is the leading cause of severe respiratory illness in infants. At ...
Respiratory syncytial virus (RSV) is the leading cause of severe respiratory illness in infants. At ...
Contains fulltext : 204143.pdf (publisher's version ) (Open Access)Respiratory syn...
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections and ...
Infants are protected from a severe respiratory syncytial virus (RSV) infection in the first months ...
Background Respiratory syncytial virus (RSV) causes respiratory disease throughout life. Here we re...
International audienceHuman respiratory syncytial virus (hRSV) is the leading cause of infant hospit...
Humoral immunityprotects against severe respiratory syncytial virus (RSV)disease, but the range andm...
Respiratory syncytial virus (RSV) is a common cause of upper respiratory tract infection in children...
Respiratory syncytial virus (RSV) represents an important target for vaccine development. The design...
Objectives: Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract inf...
The exact cause of severe disease in children during primary RSV infections is not completely clear....
The exact cause of severe disease in children during primary RSV infections is not completely clear....
Respiratory syncytial virus (RSV) represents an important target for vaccine development. The design...
Item does not contain fulltextRSV infections are a major burden in infants less than 3 months of age...
Respiratory syncytial virus (RSV) is the leading cause of severe respiratory illness in infants. At ...
Respiratory syncytial virus (RSV) is the leading cause of severe respiratory illness in infants. At ...
Contains fulltext : 204143.pdf (publisher's version ) (Open Access)Respiratory syn...
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections and ...
Infants are protected from a severe respiratory syncytial virus (RSV) infection in the first months ...
Background Respiratory syncytial virus (RSV) causes respiratory disease throughout life. Here we re...
International audienceHuman respiratory syncytial virus (hRSV) is the leading cause of infant hospit...
Humoral immunityprotects against severe respiratory syncytial virus (RSV)disease, but the range andm...
Respiratory syncytial virus (RSV) is a common cause of upper respiratory tract infection in children...
Respiratory syncytial virus (RSV) represents an important target for vaccine development. The design...
Objectives: Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract inf...
The exact cause of severe disease in children during primary RSV infections is not completely clear....
The exact cause of severe disease in children during primary RSV infections is not completely clear....
Respiratory syncytial virus (RSV) represents an important target for vaccine development. The design...